Challenges in obtaining tissue specimens from patients with brain tumours limit the
diagnosis and molecular characterisation and impair the development of better therapeutic …

Simple Summary The optimal treatment and management of patients with brain cancer
depend on the molecular characteristics of their tumour. Since the tumour changes with time …

Objective To review published nomograms that predict endpoints such as overall survival
(OS) or risk of intracranial relapse in patients with brain metastases from solid tumors …

OBJECTIVE Metastases are the most common intracranial malignancies and complete
resection can provide relief of neurological symptoms and reduce recurrence. The authors' …

Simple Summary In this comprehensive review, we focused on the neurosurgical treatment
as an integrative part of the challenging multidisciplinary management of cerebral …

The brain is one of the most common metastatic sites in non-small cell lung cancer
(NSCLC), which is associated with an extremely poor prognosis. Despite the availability of …

The appearance of brain metastases is considered a sign of bad prognosis. Treatment of
these lesions is important for quality of life, providing local tumour control, preventing death …

Background Sodium fluorescein (fluorescein) crosses a disrupted blood-brain barrier
similarly to gadolinium contrast in contrast-enhancing cerebral tumors. When exposed to …

Low-intensity MR-guided focused ultrasound in combination with intravenously injected
microbubbles is a promising platform for drug delivery to the central nervous system past the …

More than half of all brain metastases show infiltrating rather than displacing growth at the
macro‐metastasis/organ parenchyma interface (MMPI), a finding associated with shorter …